CRANIAL MAP NEURO
K-Number: K131214 · 2013-10-18
Advertisement
Device Summary
Frequently Asked Questions
What is the CRANIAL MAP NEURO?
CRANIAL MAP NEURO is a medical device that received FDA 510(k) clearance on 2013-10-18. The listed applicant is Stryker Corporate. The 510(k) number is K131214.
When did CRANIAL MAP NEURO receive FDA 510(k) clearance?
CRANIAL MAP NEURO received FDA 510(k) clearance on 2013-10-18, under 510(k) number K131214.
Who is the listed applicant for CRANIAL MAP NEURO?
The FDA 510(k) record lists Stryker Corporate as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CRANIAL MAP NEURO?
The FDA product code for CRANIAL MAP NEURO is HAW.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Stryker Corporate as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: HAW)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement